Tirzepatide 20mg is a high-purity peptide compound developed for research applications in diabetes and metabolic studies. This white powder formulation contains a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist with demonstrated efficacy in glucose control and weight management research.
The molecular structure of Tirzepatide 20mg features a lysine side chain with PEG modification, enhancing water solubility while maintaining biological activity. Research indicates this compound shows superior performance compared to selective GLP-1 receptor agonists in hyperglycemia reduction studies.
Clinical research with Tirzepatide 20mg has demonstrated significant weight reduction effects in study models, with phase 3 trials showing dose-dependent efficacy. The compound has received regulatory designations to accelerate development for metabolic conditions.
Our Tirzepatide 20mg is supplied in pharmaceutical grade purity (99.9%) with comprehensive analytical documentation. The product is packaged in sterile vials with options for custom labeling and bulk quantities to meet various research requirements.
For research purposes only. Not for human consumption. Proper storage conditions include protection from light, moisture, and temperature extremes to maintain product stability.